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[57] ABSTRACT 
Azasteroids and certain derivatives each of a five ring 
system containing at least one aromatic nucleus and at 
least one nitrogen atom. The ring system is fused to a 
tetrahydrotetralin system or a tetrahydrophenanthrene 
system. The compounds have solubility in water and 
disclose antimicrobial, antifertility and potentiate the 
activity of antibiotics and certain anticancer agents. 
6 Claims, No Drawings 
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AZASTEROIDS COMPOUNDS AND DERIVATIVES 
This is a continuation-in-part of our copending appli-
cation U.S. Ser. No. 225,593, filed Feb. 11, 1972 ,now 
abandoned; entitled AZASTEROIDS COMPOUNDS 5 
AND DERIVATIVES. 
This invention relates io. azasteroids, certai11 deriva-
tives thereof and model compounds which. contain at 
least one . aromatic nucleus and at '.least. one nitrogen.· 
atom in a 5-membered ring. 10 
The novel compositions of this invention are repre-
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wherein R represents the carbon and hydrogen atoms 
25 
necessary to complete one of the following structures: 
JOO, 
R'O . · . 
JOO 
R'O 
in which R' may be H, CH3, C2H5 or C3H7• The bridge-




be substituted by H or CH3 in which case the only 
double bond in the pyrazole ring is represented by the 50 
dashed line and the unsatisfied valences of carbon 3 are 
satisfied by two hydrogen atoms or oxygen, however, 
when the free valence of carbon 3 is satisfied by oxy-
gen, the labile hydrogen must be attached to the num-
55 ber 2 nitrogen in the pyrazole ring and when the free 
valence of carbon 3 is satisfied by hydrogen, the labile 
hydrogen atom is attached to the number one nitrogen 
of the pyrazole ring. and H is a labile hydrogen atom 
attached to one of two nitrogen atoms of the pyrazole 60 ring. It should be pointed out that the compounds of 
this invention exist in tautomeric forms, one form pre-
dominating when the bridgehead carbon. atom is substi-
tuted and the other tautomer predominating when said 
carbon atom is unsubstituted. · 
• A bridge is a valence bond or atom connecting two different parts of 65 
a molecule. The two tertiary carbon atoms connected through the 
bridge are termed "bridgeheads". 
Classes of compounds included by the above general 









7a 1/ ~N 
The substituent R in these formulas is identical to the 
values assigned R in the general formula first above 
written. R 1 may be either H or CH3 • 
Subgeneric groups coming undei: the above struc-







a. R=H, R'=H 
b. R=CH3 , R'=H 
c. R=H, R'=CH; 
d. R=CHa, R '=CHa , 







COMPOUNDS 3 COMPOUNDS 4 
a. R=H R'=H 
b. R=CH3 , R'=H 
a. R=H, R'=H 
b. R=CH3 , R'=H 
c. R=H, R'=CHa c. R=H, R'=CHa 
d. R=CHa, R'=CHa d. R=CHa, R'=CHa 




a. R=H, R'=H 
b. R' CH3, R'=H 
c. R=H, R'=CHa . 
d. R=CH3; R'=CHa . . 
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COMPOUNDS 6 
a. R=H R'=H 
b. R=CH3 , R'=H 
· c; · , R=H;R'=CH3 
d .. , .R=CH3, R'=CH, 
e. R=C2H0 or C3H7, R'=H or CH3 
R' 
COMPOUNDS 8 
a; R=H R'=H 
b. R=Ci:13 , R'=H 
d, R=H, R'=CH~ 
d. R=CHa, R'=CHa 






b. R=CH3, R'=H 
COMPOUNDS 10 . 
a. R=H, R '=ff. 
b. R=CH3, R'~H 
6 
cholesteri-3-one methiodide has been shown to irre-
versibly inhibit the growth of Bacillus subtilis cultu.res 
at concentrations as low as 1 µ,g/ml. 17-Hydroxy-17 
.a-,;nethylam.irostano[3,2]-µ, pyrazole exhibits an anti-
. 5 o';'ulatqry ,a!=tivity one-fifth .of that observed for nore-
thisterone when administered orally in rats. 
Monoazast~roids were first synthesized. in the 1930 's 
. as a "syn_thetic decarboxylase." Some of the known 
· azastefoids are. derivatives of 4,4-dimethyl-5-aandrost-
10 ) 4-ene .an.d are intermediates in steroid-terpene struc-
c. R=H, R ',,.CH3 
ii. R=CH3, R'=CH3 
c. R=H, R'=CH3 .. ' 
d. R=CH3, R'=CHa . 







a •. R=H, R'=H 
b .. R=OH, R'=H 
c. R=OCH1 , R'=H 
_d. R=OC2H1 or OC3H7, R'=H 
e. R=OCH1 , R'=F, Cl, Br 
BACKGROUND OF THE-™.VENTION 
ture correlations. It is apparent that the 15, l 6-diazas-
20 teroj<is, and· especially the 15~1J)onoazasteroids have 
be1tn little studied, despite the fa:ct that this latter class 
. of 'compounds combines· tt.e steroid nucleus with the 
: often biologically active indole nucleus in a single 
structifre. 
'25 
METHODS OF PJIBPARATION 
The preparation of compounds 5,6,8 and 9 require 
. first the . preparation of an. inte~ediate compound, 
• l ,2,3,4-tetrahydro-7-methoxy-2-m:ethyl0 1-oxo-2-
30 · ph~nanthr~nepropionic acid. The precursor of this 
acid,' the known ketone 3,4-dihydro-7~methoxy-2-
methyl- l (2H)-phenanthrone, in the quantity of 2.8 
··. grams, 0.01 ~2 mol., was placed in a 250-ml round-bot-
. tom, flask ( fitted with an addition funnel and a N2 inlet) 
35 _and_ w~ dissolved in 100 ml of warm ( 60° C) tert-butyl 
alc:ohol 'containing 0:2g of aqueous 40% KOH. The 
ketone was ohlysparirigly soluble in the alcohol and the 
reaction mixture had to be maintained at around 60° C 
to effect solution. 
40 Acrylonitrile (0.62 g, 0.0182 mol), bp 75°-78° C, 
dissolved in 10 ml of tert-butyl alcohol, was added 
d!opwis~ over a 30 minute period. The reaction mix-
ture was stirred overnight at 60° C under N2• The so1-
ventwas then removed by an aspirator, and the residue 
45 was boiled 36 hours with 50 ml of aqueous 20% KOH. 
· The reaction mixture was then diluted with H2O, 
extracted two times with ether, and neutralized with 
dilute HCL The resulting precipitate was washed with 
_H2O and air-dried to yield 3.3 g of dark-brown solid 
50 which · was · crude acid. This material was washed 
through'a 10 X 1 silica gel (35g) column with hot ben-
:. zene and recrystallized twice from 150 ml of benzene 
t6 yield 2.0 g (5·6.5%) of white, crystalline acid, (mp 
. . 157:5°-159° C); Vma:.l8t: 1680 (acid C=O) and 1655 
55 cni-1 .(ketone C=O); nmr ( 10% in DCCla) 1.22 (s, 3 H, 
CH3 ), 1.76-2'.67 (m, 6 H, aliphatic CH2), 3.13-3.47 
Steroid nuclei containing nitrogen have been. shown . (bt,2 H, benzylic CH2), 3.90 (s, 3 H, OCH3), 7.00-8.20 
to possess a wide range of physiological activities. The · '(m; 5 H, aromatic'H), and· t t.41 (s, 1 H, CO2H). 
· vast majority of these azasteroids. are derived by modi- Calculations for C1iiff20O4 disclosed: C, 73.06; H, 
fication of naturally occurring steroids. 60 6.45. Analysis found: C, 73.20; H, 6;31. 
Of the known azasteroids (3,2-c)-2'~phenylpyrazole · . The above procedure was performed successfully on 
of 9a-fluoro-6,16a-dimethyl-ti8-hydrocoftisone is ten iimes the above scale. When the condensation was 
claimed to be he most potent 11nti.:iµfl?mrriatory steroid · ;1ttemptedjri 1,4-dioxane using Triton B (benzyltrime-
known--.-over 2000 times as PQWe1::fid as hydrocorti7 . thylammonitim hydroxide) as a catalyst, the yield of 
sone_, itself. The 0~m.ethyl ether· of 16-azaesfrohe has 65 l ,2,3,4itetrahydl.'ci~ 7-methoxy-2~methyl-l-oxo-2-
exhibited significant hypochole~ierolemic activity but phenanthrenepropionic acid was only 49% and the 
possesses less than l .Q 1 % of the· estrogei:tic acfivfty of pherianthrorie recovered was unchanged in the amount 
the parent estrone. 4-Dimethylaniinoethyl~4~aza-5- of-32%:.' · · ' 
3;987,055 
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EXAMPLE I tated solid was sublimed at 250° C (0.04 mm) to yield 
2.5 g of light yellow, crystalline compound Sc 
PREPARATION OF COMPOUNDS 5 ( l,10,l l,l la-tetrahydro-1 Ia-methyl-2H-naphth[ 1,2-
The ,phenanthronepropionic acid (23 g, 0.076 mol, g]indol-7-ol) having a melting point of 287°-290° C, 
mp 155°-157.5° C) was dissolved fo 500 ml of anhy- 5 with apparent decomposition (st, under vacuum); mo-
drous, reagent grade acetone in a 1-1., three-necked, lecular weight by mass spectral analysis is 25 I ( calcu-
roun_d-bottom flask equippe<:i "Yith a thermometer, N2 lated for C11H11NO, 251.32); VmaxKBr 1600 cm-
1 
inlet, and addition funnel with CaSO4 drying'tube. The (C=N); nmr (5% in CsDsN) 1.00 (s, 3 H, CHa), 
mixture was cooled to -5° Cina salt-ice bath and 12.2 
10 
1.33-233 (m, 4 H, aliphatic CH2), 2.96-3.46 (m, 2 H, 
g (0.122 mol) oftriethylarriine was ·added dropwise, the benzylic CH2), 3.68-4.49 (m, 2 H, C=NCH2), 
temperature being kept below 0° C. Ethyl chlorofor- 7.10-8.90 (m, 5 H, aromatic H), and 11.5-12.5 (b, 1 
mate (4.7g, 0.122 mol,) was then added with the tern- H, aromatic OH). The calculated analysis for 
perature at 0° C. C 17H 17NO was: N, 5.62. The analysis found was N, 
The mixture was stirred in the cold for 30 minutes 15 5.76. 
and 10.3 g (0.16 mol) of NaN3 in 40 ml of H2O was Compound 5d (4.0 g, 0.015 mo)) was boiled for 12hr 
added dropwise, again at 0° C. The mixture was stirred under N2 with 50 ml of 48% HBr. The mixture was 
at 0° C for 1 hr and poured into ice water. cooled and filtered through a glass-fritted funnel and 
A crystalline crude azide that separated amounted to the solid isolated was dissolved in 1 liter of warm (50° 
18.0 g and decomposed with · partial melting at 20 C) aqueous 2% NaOH. The basic solution was filtered 
90°-100° C (sealed tube _under vacuum). The azide was and neutralized with dilute HCI (pH 6.5 to<7). The 
dissolved in 500 ml of toluene and heated on a steam resulting selution was made basic with excess aqueous 
bath until gas evolution ceased ( 1-2 hr). Toluene .was 10% NaHCO3 . The solid thus obtained was filtered, 
removed in vacuo; the residue amounted to_ 16.0 g of vacuum-dried, and sublimed at 250° C (0.04 mm) to 
crude isocyanate which was heated at reflux for 24 hr 25 yield 2.9 g of the compound Sc identical with the mate-
with 300 ml of 1 : 1 : I · H2O-glacial acetic acid-concen- rial described above. 
trated HCI. The mixture was cooled, diluted (H20), The preparation of compounds Sa, Sb and Se can be 
extracted 3 times (ether), filtered, and then neutralized accomplished using similar techniques _to those de-
(aqueous 10% NaHCOa). . scribed above to prepare compounds 5c and 5d. Fol-
The resulting yellow soiid (9.0 g), which_had a very 30 lowing the procedure above but substituting 3,4-dihy-
broad melting range (120°-200° C), was warmed dro-7-methoxy-(or ethoxy or propoxy)-l-oxo-2-
(500-600 C) with 150 ml pf benzene, and the mixture phenanthrenepropionic acid for 3,4-dihydro-2-methyl-
was filtered. The residue was again extracted with. an l-oxo-2-phenanthrenepropionic acid, one can obtain 
additional 150 ml of benzene. The filtrates were com- Sa and Sb (or Se). 
bined and reduced to 150-ml total yolume by boiling on 35 The preparation of compounds 8 and 9 begin with 
a hot plate. Cooling the solution to room temperature the compound l-keto-1,2,3,4,9, 10-hexahydro-
caused it to deposit a small additional quantity of mate- phenanthrene disclosed in the Journal of American 
rial. This solution was then filtered and the benzene- Chemical Society, Volume 64, Page 979, 1942, follow-
insoluble residues (crude compound Sc) were com- ing techniques similar to those described above to pre-
bined and set aside. 40 pare compounds Sc and Sd. 





1 cm column of neutral alumina (50 g) and the column 
was washed with additional benzene until no further 
material was eluted. The colorless benzene eluate was 
evaporated to dryness under aspirator vacuum. The 45 
white, amorphous residue was. crystallized from ace-
tone and then sublimed at 150° C (0.04 mm) to yield 1-Tetralone (24.5 g, 0.168 mol) was converted to 
27.3 g (92%) of the known crude hydroxymethylene 
compound essentially by the method reported in the 
so literature [Journal of American Chemical Society, 66, 
218 (1944) and Bl,lll. Sdc. Chim. France, 556 (1958)]. 
5 .0 g of compound 5d ( 1, 10, 11, 11 a-tetrahydro-7-
methoxy-11 a-methyl-2H-naphth[ 1,2-g]indole) mp 
180°-181° C (st, under vacuum); molecular weight by 
mass spectral analysis in 265 ( calculated for C18H19NO, 
265.34); VmazKBr 1600 cm-1 (C=N); nmr (10% in 
DCCl3 ) 1.11 (s, 3 H, CH3 ) 1.65-2.50 (m, 4H, aliphatic 
CH2), 2.94-3.47 (m, 2 H, benzylic CH2), 3.78-4.25 (m, 
C=NCH2} and 3.90 (s, OCH3 } (total 5 H), and 55 
7.06-8.27 (m, 5 H, aromatic H). 
The calculated analysis for C18H19NO was C, 81.47; 
H, 7.22; N, 5.28. The analysis found was C, 81.70; H, 
7.30; N, 5.29. 
The insoluble residue from the benzene extraction 60 
was dissolved in 800 ml of warm (50°-60° C), aqueous 
2.5% NaOH. The NaOH solution was cooled and fil- The crude prodµct was condensed with 1-butanethiol 
tered to remove a very small quantity of insoluble resi- in the presence of p-toluenesulfonic acid to give a 
due. The solution was then made acid with dilute HCI, quantitative yield of crude 2-(n-butylthiomethylene)-1-
the acidified solution being held near 40° C to prevent __ 65 tetralone. The crude _thioether (21.6 g, 0.088 mo)) in 
crystallization of what was apparently a sparingly solu- · aqueous base ( =3:_1, H2O:NaOH was reductively desul-
ble hydrochloride. The warm, acid solution was neu- furized employing deactivated Raney nickel in an open 
tralized with aqueous 10% NaHCO3, and the precipi- beake.r at 75° C for 1 hour. 
3,987,055 
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The yield of 2-methyl-1-tetralone was 17 g (94% ), 
identical with authentic material by comparative glpc 
analysis. The 2-methyl- l-tetralone was converted in 
98% yield to 1,2,3,4-tetrahydro-2-methyl-l-oxo-2-
naphthalenepropionic acid (crude) by the method de- 5 
scribed earlier for the preparation of the phenanthrene-
propionic acid. 
The crude naphthalenepropionic acid (a viscous yel-
low oil) was converted to the benzindole (Compound 
l) by the same method described earlier for the prepa- IO 
ration of the compound 5d. Compound l was produced 
from the acid in 45% yield.as a water-white liquid: bp 
84°-87° C (0.04 mm); homogenous by glpc analysis; 
VmazKBr 1620 cm-1 (C=N); nmr (neat) 0.88 (s, 3 H, 
CH3 ), 1.15-2.17 (m, 4 H, aliphatic CH2), 2.20-3.15 15 
(m, 2 H, benzylic CH2), 3.50-4.20 (m, 2 H, C=NCH2), 
6.76-7.23 (m, 3H, aromatic H), and 7.88-8.22 (m, 1 
H, aromatic H wi.th ortho keto function). The analysis 
of this material was calculated for C13Hu;N was: N, 
7.56; the analysis found was: N, 7.73. 20 
EXAMPLE III 
,· Preparation of 
10, 11-Dihydro-7-methoxy-3H-naphth[ 1,2-g]indazole 






Compound 1 la. 
The methyl ether compound l lb (0.50 g.,0.0020 
mole) was boiled with 25 ml. of aqueous 48% hydro-
bromic acid for 12 hours under nitrogen purge. The 
mixture was cooled, made strongly alkaline with aque-
ous l 0% sodium hydroxide and filtered. The alkaline 
filtrate was neutralized with dilute HCI (pH 6.5 to< 7). 
The resulting solution was treated with aqueous l 0% 
sodium bicarbonate solution and the resulting gray 
precipitate was filtered and sublimed at 240° C/0.03 
mm. to yield 0.4 g. ( 85% of compound 1 la as a light 
orange crystalline solid (m.p. 258°-261 ° C,s.t., vac.; uv 
Amax (sodium salt in water) 257.5 mµ. (log= 4.594); 
nmr (perdeuteriopyridine)82.70-3.59 (m, 4H, CH2), 
7.16-8.82 (m, 6H, aromatic and vinyl H), and' 
12.1-14.1 (b, 2H, OH and NH). The indazolol com-
pound Ila (0.2 g.) was recrystallized from 1:1:1: mix-
ture of pyridine: benzene:cyclohexane and then sub-
. limed again as above to yield 0.15 g. of a white, crystal-
line solid, m.p. unchanged. An analysis of this material 
was calculated for C15"12N2O as follows: C, 76.25; H, 
5.12; N, 11.86 and was found to be C, 76.52; H, 5.26; 
N, 12.00. 
EXAMPLE V 
Preparation of 4,5-Dihydro-lH-benz[g]indazol-7-ol 
Compound 2 
4,5-Dihydro-7-methoxy-lH-benz[g]indazol was pre-
pared by a method known in the.art. This compound, 
35 ( 10.0 g., 0.0500 mole, m.p. 162°-163.5°C), was boiled 
with 250 ml of aqueous 48% hydrobromic acid for 12 
hours under nitrogen purge. The mixture was cooled . 
and filtered, and the resulting pink solid was dissolved 
(3.5 g., 0.0154 mole) was added to a stirred mi_xture of 40 in 200 ml. of aqueous 6% sodium hydroxide. The alka-
1.7 g. (0.0315 mole) of sodium methoxide, 2.3 g. line solution was filtered and neutralized with dilute 
· .(0.0312 mole) of ethyl formate and 50 ml. of benzene · HCl (pH 6.5 to <7). Treatment with 10% sodium bi-
under nitrogen in a 100 ml, round bottom flask. carbonate solution yielded 6.8 g, (73%) ofan off-white 
The mixture was stirred for 6 hours and then poured powder, co~pound 2 (m.p. 198°-203° C, s.t., vac.). 
into one liter of ice water; the resulting mixture was 45 . An analytical s~ple of compaund 2 w,,as recrystal-
extracted with 300 ml. of ether. The organic phase was : hzed_ from acet~mtrile and ~ubhmed ( 1_80 /0.~3 mm.), 
washed with 500 ml. of aqueous 5% sodium hydroxide; · to yield a white, hard, microcrystallme sohd (m.p. 
the aqueous extracts were combined, and the com- 206.5°-208° C s.t., vac);uv Amax (water) 270 mµ. (loge 
bined extracts were acidified with excess concentrated = 4.196); nmr (perdeuteriopyridine) 82.78 (bs, 4H, 
hydrochloric acid. The precipitated solid material was 50 CH2), _6.78-8.12 (m, 4H, aromatic and vinyl H), and 
filtered out and vacuum-dried to yield 2.8 g. (72%) of 12.4 (bs, 2H, OH and NH). An analysis of this material 
3,4-dihydro-2-(hydroxymethylene)-7-methoxy-1(2h)- was calculated for C11H10N2O as follows: C, 70.95, H, 
phenanthrone as a yellow powder. This. material (2.8 5.41; N, 15.05 and was found to be C, 70.85; H, 5.37; 
g., 0.011 mole) was dissolved in 300 ml. of methanol, l'l, 14.81. 
and 3 ml. of 95% hydrazine was added. The solution 55 Compounds 6 are prepared using similar techniques 
was stirred 4 hours and then reduced to 50 ml. in vol- to those described for the preparation of compound 2, 
ume by boiling on a hot plate. Upon cooling, 1.7 g. of except that the starting material is 3,4-dihydro-7-
the compound 1 lb separated as feathery, yellow nee- methoxy-2-methyl-1(2H)phenanthrone. 
dies (softened at 190° C, m.p. 212°-213° C, s.t., vac.). Compounds 3 are prepared using similar techniques 
This material was recrystallized from 200 ml. of ben- 60. to those described for the preparation of compound 2, 
zene, yielding 1. l g. of compound 11 b as a white pow- except that the starting material is 6-methoxy-1-tetra-
der (m.p. 212.5°-2.14°, s.t., vac.); uv >.. max (ethanol) lone. 
266.5 mµ. (log.=4.537); nmr (perdeuteriopyridine) 
82.76-3.57 (m; 4H, CH2 ), 3.81 (s, 3H, OCH3 ), 
7.17-8.85 (m, 6H, aromatic and vinyl H), and 65 
13.5-14.9 (b, IH, NH). 
The analysis of this compound was calculated for 
C1sH14N2O as follows: C, 76.78: H, 5.64; N, 11.19 and 
was found to be C, 76.88; H, 5.75; N, 11.02. 
EXAMPLE VI 
Preparation of Compounds 4c and 4d. 
6-Methyoxytetralone (68.2 g, 0.328 mole), dimethyl 
carbonate ( 416 ml, 0 .448 mole), and sodium methox-
ide (24.2 g, 0.448 mole) were placed in a 1000 ml 
flask. The mixture was heated at reflux for 2.5 hours 
3,987,055 
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ind allowed to cool. Methanol (200 ml) was added to 
dissolve the precipitate and an additional 200 ml. of 
methanol and 91.4 g (0.644 mole) of methyl iodide 
were added. The mixture was stirred overnight at room 
temperature. 5 
The solution was brought to a boil and neutralized 
(2N acetic acid). The volume of solution was reduced 
by distillation by about one-half. Upon cooling, crystals 
of the following keto ester compound precipitated: 
10 
12 
The known phenanthrone 
~o 
( I. 75 g, 0.0078 mole) and a large excess of dimethyl 
15 carbonate (45 ml, 0.534 mole) were stirred together 
for 5 minutes in a 200 ml round bottom flask equipped 
as usual. Sodium methoxide (0.484 g, 6.0089 mole) 
was added and the solution was heated to a boil (the 
The yield was 82% (54.0 g) based upon 6-methox-
ytetralone. The melting point was 91.5°-92.5° C (s.t.) 
20 
which was in agreement with a literature value for the 
compound prepared by a known method. 
The ketoester compound (14.8 g, 0.059 mole) and 
hydrazine ( 19.2 g, 0.60 mole) were stirred in a flask 25 
under N2 at room temperature for 4 hours. Absolute 
methanol was added to keep the mixture fluid along 
with 5 g of hydrazine. 
Water (200 ml) was then added and the mixture was, 
stirred for 0.75 hours. The mixture was then filtered, 30 
and the residue was washed ( 100 ml of water) three 
times. The white, solid compound 4d was vacuum-dried 
at 50° C; yield 12.29 g (90.5%) m.p. 217.5°-218.5°. 
An analysis of this material was calculated for 
C 13H 14N 20 as follows: C, 67.81; H, 6.12; N, 12.17; and 35 
was found to be: C, 67 .69; H, 6.22, N, 12.34. 
Treatment of compound 4d with 48% HBr as de-
scribed previously for conversion of compound 5d to Sc 
gave crude compound 4c which was dissolved in 6% 
NaOH and heated over activated charcoal. The solu- 40 
tion was filtered and neutralized (50% aq. acetic acid) 
and allowed to cool. A fine precipitate of compound 4c 
formed. An analysis of this material was calculated for 
C 12H 12N 20 2 as follows: C, 66.66, H, 5.55; N, 12.96 and 
was found to be: C. 66.29; H, 5.59; N, 12.63. 45 
Compounds 4a, 4b, 4e and 4f are prepared in similar 
fashion. Compounds 7 are prepared using the same 
techniques as compounds 4e and 4d, except that the 
starting material is 3,4-dihydro-7-methoxy-2-methyl-
l (2H)-phenanthrone. Compounds 10 are prepared 50 
using the same techniques as compounds 4c and 4d, 
except that the starting material is 1-keto- l ,2,3 ,4, 9, 10-
hexahydrophenanthrene. 
Compound 12 may be prepared using techniques 
similar to those employed in preparation of compound 55 
2, starting with the same phenantrane compound used 
as a starting material for the production of compound 
1 lb. For further information on the general techniques 
used in the preparation of compound 12, reference 
may be made to Proceding of Oklahoma Academy of 60 
Science, Volume 4 7, Page 215, 1966 issue, published in 
1968. 
color turned red to dark red in 15 minutes.). A reddish 
precipitate appeared in 15 minutes, and heating was 
stopped. After stirring for 15 minutes the mixture at-
tained room temperature and 30 ml of CH30H ( abso-
lute) was added. The precipitate dissolved. Methyl 
iodide (0.852 g, 0.006 mole) was added and the result-
ing mixture was stirred overnight at room temperature. 
One ml of CH31 was added and the mixture was 
heated gently for 5 minutes and then cooled to room 
temperature. The mixture was acidified with 2N acetic 
acid, (pH 6.7) evaporated to about ¼ volume, and 
cooled in a refrigerator. A tarry substance precipitated; 
it was washed with water and then extracted ( 2 times) 
with ether. The extracts were washed with H 20 and 
finally with saturated NaCl solution. The solution was 
dried (MgSO4 ) and filtered. Evaporation of the ether 
gave an oil which was used immediately. It was pre-
sumed to be crude keto ester: 
This compound was dissolved in 30 ml. of absolute 
CHaOH (under N2 ) and 6 g (0.187 mols) of hydrazine 
(95%, Eastman Kodak) was added. The color changed 
to orange and a yellow solid formed after 3 hours of 
stirring without heating. Water was added (75 ml) a · 
the resulting mixture stirred for an additional 2 to 5 
hours. Crystals formed and were filtered. Sublimation 
gave 1.54 g (73% of compound 7d), m.p. 258°-260° C. 
VmaxKBr 1690 cm-1 (C=O). 
The calculated analysis for C 17H 16N20 2 was C, 72.86; 
H, 5.71; N. 16.00. The analysis found was C, 72.73; H, 
5.62; N, 9.86. 
PROPERTIES OF THE COMPOUNDS 
EXAMPLE VII 
Preparation of 2, I 0, 11, 1 la-
tetrahydro-7-rnethoxy- l la-rnethyl-l H-phenan-
thro[ 1,2-c ]-pyrazol-1-one Compound 7d 
65 We now wish to describe valuable properties of these 
members of the azasteroid family and related, simple 
model systems. These compounds have shown antimi-
crobial activity, antifertility activity, anticancer activity 




The hydroxybenzindazole (compound 2) delayed 
(inhibited) the initiation of growth of selected unre-
lated bacteria when incorporated ;n the growth me-
dium. The inhibition was dependent on the concentra-
tion of the test compound and th.e nature of the organ-
ism. Bacillus subtilis W23 and Escherichia coli B were 
sensitive to 86 µ.g/ml as indicated by the increased lag 
(approximately 3 hours) in the initiation of growth with 
only slight inhibition observed in the lower concentra-
tio~ ( 46 µ.g/ml). Pseudomonas fluorescens NND was 
not sensitive to the hydroxybenzindazole in the concen-
. trations tested. 
The influence of cell mass on the antimicrobial po-
tential of the hydroxybenzindazole was determined 
using B. subtilis W23. A direct relationship exists be-
tween cell mass and the concentration of the inhibitor 
since the extent of inhibition was diminished as the cell 
mass of the inoculum was increased. Thus, a critical 
number of molecules must react with the cell to produce 
inhibition. Experiments were conducted to determine if 
Mg++, which is an important component of cell mem-
branes, affected the inhibition. Cells of B. subtilis W23 
were exposed to 10-3M MgC12 simultaneously with the 
test compound or for as long as 15 minutes prior to 
addition of the hydroxybenzindazole. Growth studies 
indicated that Mg ++ did not influence the inhibition 
when added at either time, establishing that the test 
compound did not interfere with the Mg++ interaction 
. and function in the membrane. 
Although the hydroxybenzindazole did not influence 
the 'growth of P. fluorescens NND, approximately 95% 
of the cell population lysed (burst) when cells were 
grown in the presence of the hydroxybenzindazole. The 
extent of lysis ( cell rupture) was proportional to the 
benzindazole concentration. Control cells did not lyse 
during the experiment. The increased lytic rate was not 
observed when the benzindazole was added after the 
cells had reached the maximum stationary phase ( 10 
hours); thus, the compounds must be present during 
active growth for the cells to show the lytic response. 
These results suggest the compound changes the "ar-
chitectural configuration" of the cell creating a more 
fragile structure which bursts; thus the cell is com-
pletely destroyed. This is extremely important in con-
trolling or destroying growth of undesirable cells since 
if the cells rupture they cannot possibly grow and di-
vide at any future time. 
Several antibiotics act at the cell surface. The antimi-
crobial activity of the hydroxybenzindazole in combi-
nation with selected antibiotics· was measured. The 
hydroxybenzindazole and penicillin, when tested sepa-
rately, produced a very slight inhibition of growth. 
However, a combination of the benzindazole and peni-
: dllin showed a pronounced inhibition in the growth of 
' B. subtilis W23. 
14 
The enhanced inhibition was not observed when the 
hydroxybenzindazole was · used in combination with 
chloramphenicol. Failure of the mixture of hydrox-
ybenzindazole and. chloramphenicol to show an .en-
s hanced inhibition of growth could be correlated with 
the internal site of action of chlorampherticol, which is 
blockage of the binding of the 30s and 50s ribosomal 
subunits. While the benzindazole does not alter the cell 
permeability, at least to chloramphenicol, it may distort 
IO the integrity of the outer cell structure and thus facili-
tate or complement · the action of the surface active 
compounds . 
Quantitative studies revealed that when cells were 
incubated with 20 µ.g of the hydroxybenzindazole ap-
15 proximately .1 µ.g was bound or adsorbed to the cell. 
The hydroxybenzindazole (60 µ.g/ml) did not inhibit 
uptake or incorporation of L-serine-3-14C or uracil-2-
1"C which augments the findings obtained with chlo-
ramphenicol sensitivity with its intracellular site of 
20 action. Addition of the hydroxybenzindazole to osmo-
plasts ( osmotically sensitive cells) of B. subtilis W23, 
stabilized in 0.35 M sucruse, did not. produce lysis. 
Failure of the benzindazole to alter uptake of the amino 
acid and purine base or to facilitate lysis of osmotically 
25 sensitive structures, suggests that the compound pro-
duces conformational changes in the membrane, but 
these changes do not results in ~ loss of cellular integ-
rity with subsequent lysis. Th~s the compound can be 
. used to destroy undesirable cells without damaging 
30 normal cells . 
Inhibition studies using the microorganism B. subtilis 
W23 indicated that. compounds 4 and 7 completely 
inhibited the growth of the organism. The results indi-
cate that compounds 4 and 7 ·are biologically active and 
35 are ·potential antibacterial agents. . 
Members of this class of compounds also inhibit 
growth of human and mouse cells .. For example, gr:owth 
of both the human tumor KB* and the mouse L-M** 
cell lines was inhibited when the cells wei:e grown in 
40 media containing µg/ml or greater concentrations of 
either compound Sc or 5d indicating their potential 
function as anticancer agents; Cultures containing 
1 µg/ml of either compound 5c or 5d had the same growth 
45 
rate as the control. During the first 2 days of growth, 10 
µg/ml of either compound reduced the growth by 25 to 
50 percent. By the fourth day cultures containing 10 
µg/ml compound Sc remained at 50% of the control while 
cultures containing compound Sd showed only a 30% 
reduction in growth as compared to the control. Increas-
50 ing the concentration of compound Sd to 20 µg/ml 
depressed the growth rate only slightly over · the rate 
observed with 10 µg/ml. However, when the concentra-
tion of compound Sc was increased to 20 µg/ml, a marked 
inhibition was observed with no significant increase in 
55 cell numbers after three days. The low concentrations 
required for inhibition establish these· compounds as 
potent inhibitors- probably among the top 5% of 
compounds presently in use. Similar potentiation was obtained when the hydrox-
ybenzindazole was used in combination with either 
polymyxin (5 µ,g/ml) or circulin (30 µ.g/ml). Both Poly- 60 
myxin (Pfizer, Inc.) and Circulin (Upjohn Co.) are 
surface active compounds thought to cause disorgani-
zation of the cell membrane leading to a loss of intra-
cellular components. The enhanced antimicrobial ac-
tivity observed with the combination ofhydroxybenzin- 65 
dazole and antibiotics denotes a more pronounced 
distortion in the cell surface. Thus, much lower con-
centrations of the compounds can be used in medicinal 
applications providing an opportunity for toxic com-
pounds to have greater medicinal applicability and use. 
*The KB cell line was derivc;d from an epidermoid carcinoma in' the 
mouth of an adult male caucasian in December, 1954, by H. Eagle 
(Proc. Soc. Exp. Biol. Med., 89:362,1955). It was one of the early 
successful attempts to isolate and serially propagate a human cell line 
directly in monolayer culture on glass. The line was isolated in a 
medium consisting of basal medium (Eagle), 90%; human serum, 10%; 
and in the course of 350 subsequent passages has been adapted to 5% 
calf serum, · . . 
**The L-M strain was derived from NCTC clone 929 (see CCL I) by 
R. J. Kuchler and D. J. Merchant during the course of studies on its 
nutritional requiremen,s (Proc. Soc: Exp. Biol. Med., 92:803, 1956; 
Exp. Cell Res., 17:490, I 958). L-M is characterized by its propagation 
in a serum-free medium (Morgan, Morton, and Parker's medium 199 
with Bacto-peptone 0.5% or 2X Eagle amino acids and vitamins; Proc. 
Soc. Exp. Biol. Med., 110:194, 1962),and by marker chromosomes (J. 
Nat. Cancer Inst., 26:1075, 1961). 
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To ascertain if the potency of compound 5d was 
reduced during the incubation in the growth medium in 
the absence of cells, compound 5d ( 20 µ,g/ml) was 
added to the medium and incubated at 3 7° C on a 
shaker for 4 days. Cells ( 1 X 105/ml) were added to the 5 
·••incubated" compound~-coniaining -medium. The inhi-
bition pattern obtained from the "incubated" medium 
was identical to that obtained when compound 5d (20 
µ,g/ml) was added simultaneously with the inoculation. 
These results show that detoxification of the compound IO 
by either auto-oxidation or enzymatic processes asso-
-Animal Test 
___ 16 _ _ 
EXAMPLE IX 
Antitumor Activity of Compound 11 a and 
Antinomycin D in mice. 
The test system utilized involved Swiss albino CD- I 
female mice weighing 25-27 grams which were in-
jected (i.p.) with 1 x 106 viable sarcoma 180 ascitis 
cells. Chemotherapy was initiated 24 hours post-injec-
tion with a protocol of five intra-peritonaeal injections 
at 24 hour intervals. 
Test Regime 
Groups Compounds Quantity Injected 
I actinimycin D 4 µg/injection - total 20 µg 
0.8 µg/injection - total 4 µg 2 compound I la 
3 actinomycin D 4 µg/injection and 0.8 µg/injection 
plus compound 11 a 
4 saline 0.2 ml/injection 
ciated with the serum does not occur during continued 
incubation in the culture medium. Since the com-
pounds are not inactivated by serum, their effective-
ness for animal use or human tests is enhanced. This 
fact is stressed in animal studies recited in Example IX 
below. 
25 Animals were weighted at 24 hour intervals and the 
survival time recorded for each test group. 
Results - Test to Control 
Survival Ratios 
Survival time of the test animal (T/C) 
Survival time of the control animal 




The KB cells were plated in plastic tissue culture 
dishes and grown in a 5% CO2 gas phase incubator for 
7 days. The medium was removed, the plates washed 
with Hanks' salt solution and the cells stained with a 35 
0.5% aqueous crystal violet solution, rinsed and dried. 
The colonies were counted and the relative plating 
efficiency calculated using the number of control colo-
nies as 100 percent. The effect of compounds Sc and 5d 40 




Relative plating efficiency (%) 




Compound 11 a 
Actinomycin D 
Compound I la plus 
Actinomycin D 4.3 . 
(National Institutes of Health guide lines indicate that 
compounds or combination chemotherapy agents hav-
ing a T/C ratio greater than 1.25 in the mouse tumor 
system are of potential use, Cancer Chemotherapy 
Reports, No. 25,Dec. 1962). The life span of mice with 
the sarcoma tumor is significantly prolonged by treat-
ment with a combination of the test compound I la and 
antinomycin D(T IC = 4.3) establishing an enhance-
ment of anticancer activity by the test material. 
COLONY AND CELL MORPHOLOGY 
KB cells exposed to 10 and 20 µ,g/ml of compound Sc 
did not divide, or if limited division occurred, only a 








79 50 number of cells. Differences in cell morphology were 
also observed. In contrast to the control, the nuclei of 
treated cells were located at the periphery of the cell 
which contained. little cytoplasm. In addition, treated 
cells had a less uniform density with areas of heavy and 
55 light staining. Since the difference in staining density 
could be the result of modification of intracellular 
structures, such as lysosomes~- experiments were per-
formed to determine the effect of the compounds on 
the permeability of lysosomal membrane. 
The greater sensitivity of L-M cells to compound Sc 
was also evident with KB monolayer cultures (Table 1 ). 
The colony formation of KB cells (7 days cultures) 
showed a 38% (62% of the cells were killed) relative 
plating efficiency in the presence of 10 µ,g/ml of com- 60 pound Sc and a 17% relative plating efficiency (83% of 
the cells were killed) when 20 µ,g/ml of compound Sc 
was added to the growth medium. In contrast, com- _ 
pound 5d produced only a very slight inhibition of 
growth when compared with the control culture, with 
no significant difference observed between the 10 and 65 
20 µ,g/ml concentrations. As with L-M cells 1 µ,g/ml of 
either compound Sc or compound 5d had little effect. 
on the relative plating efficiency. 
EXAMPLEX 
Relative Acid Phosphatase Staining of KB and L-M 
Cells Grown in the Presence and Absence of 
Compound Sc and Compound 5d. 
KB and L-M cells 'were grown on coverslips in me-
dium 199 with 10% calf serum for the 24 hour growth 
prior to staining in the presence or absence of com-
pound Sc (20 µ,g/ml) or compound 5d (20 µ,g/ml). The 
3,987;055 
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cells were washed in Hanks' salt solution, incubated at 14C-leucine (5 pCi), was ac;lded to suspension cultures -
37° C in Gomori's substrate solution for l, 2, or 3 of.L-M cells (8 X 105; /ml) in McCoy's 5a modified 
hours, washed, treated with a 1 % solution of ammo- medium cpn~ining' eitber ffor' 15 µg/ml of compound 
nium sulfide, washed, mounted and observed micro- 5c. The cells were incubated at 37° C. One ml samples 
scopically. Light staining was designated as cells show- -5 were removed at varying intervals and the rates of 
ing only a few scattered granules; medium staining was uptake and incorporation were determined from the 
more dense but distinct _isolated granules were still ' liner poi::tion of radioactivity versus time curves. 
detected; and heavy staining a more intense staining 
with fewer discrete granules. Heavy staining. denotes 
increased phosphatase activity. 10 TABLE 3 
TABLE 2 
Incubation time 
in substrate Treatment Substrate Addition 
(Hours) none compound Sc compound Sd 
----------,---:--------~ 15 3H-thymidine. none 
I none light none colnpound Sc · 
2 light 'medium light 3H-urid,ine none 
3 medium- :heavy medium compound Sc 
20 
EFFECT ON PERMEABILITY·OF L YOSOMAL' · 
1'C_-leucin~- ... , no!le , 
· compound Sc 
Rate 
















MEMBRANES , . 
·· · · · EFFECT ON UPTAKE AND INCORPORATION · 
The · acid phosphatase activity ~~ meas:u~ed in · KB , • • 
the up· take of radioactive thy· midine, uridine, and_ and L-M cells grown ·in·· medium in .· the presence or . 
absence compound 5c or 5d (20 µg/ml) for 2 or 24 25 leucine, precursors for DNA, RNA and protein, respec-
hours prior to staining (Table 2). Quantitative evalua- tiyely, ~a,s i11hipitecl_when suspension cultures ofL-M 
tion of the relative staining intensity of the ly$osomes cells .. were· iric4bated in .the prese_nce . ?~ 15 µg/ml ?f 
was compared in the treated and untreated cells. Jbe compound, Sc (Table 3 ). The rad1oacttv1ty present m 
staining intensity of the cells treated for 2 hours was .~e PQ<Jl for each of the precursors was reduced by 
indistinguishable from untreated cells. However, differ- 30 ab6ut · 66% showing_· that the inhibition was not sub-
ences . were noted for cells grown for 24 hours.- Cells strate specific but that all substrates wei:e inhibited, and 
grown in the presence of compound 5c showed light the decreased pool levels could .account for the. de-
staining after t hour incubation in the substrate while creased incorporation into the macromolecules that 
the control and compound 5d treated cell!! did not was observed. These results augment the previous find-
stain. For all three substrate incubation times, the con- 35 ings that regulation (inhibition) of the ability of cells to 
trol and compound 5d treated cells showed identical accumulate essential metabolites (food) by these com-
staining reactions while compound 5c treated cells pounds makes them excellent anticellular agents. To 
:showed a more intense .staining reaction. Thus, cells further stress the importance of the compounds these 
grown in the presence of compound 5c accumulate the results also indicate an inhibition of synthesis of DNA 
phosphatase substrate within the lysosomes much more 40 (nuclear material), RNA and proteins which is essen-
rapidly than the control or compound 5d_ treat~d cells · tial to controlling cell growth and division, especially in 
indicating the compounds ability to alter membrane malignant ce,ls. · 
permeability and thus regulate the accumulation of 
ess~n~al metaqolites. Gon~o_l _of this_ cellular c!pacity ,i.5 THE EFFECTS OF THE AZASTEROIDS ON TESTIS 
penmts :regulation of cell d1v1s1on so important 1n can- •· · · FUNCTION 
cer chemotherapy; Since the permeation of the sub-
strate •is the rate-limiting step in the phosphatase d~ter- . The compounds as shown in Table 7 were dissolved 
mination;.compound Sc produces a modification of the . in a minimal.amount of ethanol and diluted in sesame 
Iysosomal membr~e which inc:rtiased the permeability 50 ; oil ( t mg/~l). After dilution, samples were stored at 5° 
of the lysosome . to the substrate. The results ali,o em- .. · C · in the dark and flushed with N2 every 24 hours. The 
phasize · the difference . in biologica! activity. of com- · compound~ were injected subcutaneously into adult 
p_ou_nd Sc and 5d type mol~culeswh1~h chem1~ally _are male mice for a period of 10 days. Each mouse injected 
s1mdar except at C-3. Differences m .the b10log1cal received a tptal dose of 2 mg over the 10 day period or 
activity have been observed when the compounds ~ere 55 0.2 mg per day. The mice were random bred males· of 
~ested using various bacteria. Jn experiments not ·· the ICR-Swiss strain and were used in the study when 
shown, the treatment of cells wi!h T~ton X-1 OO ( octyl . they reached 75±2 days of age. Mice were maintained 
phenoxypolyethoxyethanol) which is known to _al_ter in air-conditioned and light-controlled (14 hour 
cell permeability resulted in the. same final sta1m11g ,, Iigl:it/24.hour) animal quarters and provided with lab 
intensity as growth in the presence of compound 5c. 60 food'and water ad libitum. Animals were necropsied 24 
Thus, this cqntrol experiment in~icated cpmpou.nd 5c hours after the last injection. Testes and seminal vesi-
does not induce synthesis of acid phosphatase 10 the cles "were excised, trimmed of adhering tissue and 
cell but does alter cell permeability• weigh,ed fresh at the nearest one-tenth milligram .. The 
EXAMPLE XI. 
Effect of Compound 5c. ( 15 µ,g/ml) on Uptake and 
Incorporation of 3H-Thymidine, 3H-Uridine and 
14C-Leucine by L-M Cells. 
3H-Thymidine (10 µ.Ci), or 3H-uri(line ( 10 µCi), or 
results .of the weight studies are shown in Table 4. No 
65 'significant changes in the testes weight or total body 
weight .were noted indicating the compounds do not 
produce adverse effects in animals, ~hich is very im-
. portant if compounds are to be used in human medici-




Average Body, Testis and Seminal Vesicle Weight 
After Treatment with Various Azasteroids 
Testes 
JO 
Paired Mg Testes Seminal 
Compound No. of Mice Body Weight Testes Per g Body Vesicle 
Number . Treated (g) (mg) Wt. 
4c 2 35.7 261.0 7.28 
2 4 35.7 242.0 6.73 
Sd 5 32.3 201.6 6.32 
Sg 5 34.3 · 178.0 5.20 
118 2 34.0 229.0 6.67 
Sesame Oil 
alone 5 34.0 223.5 7.35 
IN VITRO TESTIS METABOLISM STUDIES 
For these investigations the compounds were diluted 
in a minimal amount of ethanol and further diluted in 
saline (0.85%) so that the final concentration was 1 
20 mg/ml. The compounds were placed in solution and 
gassed under N2 and stored at 5° C until used 2 days 
later for the in vitro incubation studies. Details of the in 
vitro incubation procedures may be found in Endocri-
nology 89:791-800 (1971). 
The effects of these compounds. on glucose oxidation 25 
by testis tubules was examined by incubating about 200 
mg of teased testis tubules from mature rats in a 25 ml 
Erlenmeyer flask containing 3 ml of Krebs Ringer bi-
carbonate buffer (pH 7.4), D-glucose-U-14C (0.5 µ.Ci; 30 lOmM) and 0.25 ml of the azasteroid ( 1 mg/ml) to be 
tested. The flasks were incubated for 2 hours at 33° C 








adding 0.25 ml of 5 N H2SO4 • Carbon dioxide was 
trapped in 0;25 ml of hydroxide ofHyamine. The radio-
activity present in the Hyamine was determined by. 
liquid scintillation spectrometry. The results of this 
study are summarized in Table 5. This table includes a 
detailed summary of the results obtained and an aver-
age for ea~h compound. In this assay compounds. 2, 5c. 
and 5d depressed glucose oxidation in vitro more than 
compounds 4c and 1 lb. The latter compounds were 
comparable to saline. Reduction of oxidative potential, 
so important in sperm development, suggests interfer-
ence with spermatogenesis indicating action as antifer-
tility ag~nts. These results were confirmed by sperm 
counts and failure of female mice to conceive when 
placed with males treated with these compounds. Thus, 
the compounds have potential for antifertility activity 
in the control of wild rodent populations and possibly 
stray animals such as dogs and cats. 
TABLE 5 
EFFECT OF COMPOUNDS ON GLUCOSE OXIDATION (GLUCOSE-U-1'C) 
BY RAT TESTIS TUBULES 
TISSUE (mg) 
COMPOUND TISSUE ACTUAL 
FLASK NUMBER + WEIGHT WEIGHT GLUCOSE OXIDATION 
NUMBER TESTED TARE TARE TISSUE CPM/FLASK CPM/100 mg 
I Saline 463.43 261.67 201.7 23,441 11,621 
2 4c 464.17 268.04 196.13 17,350 8,847 
3 2 476.41 271.44 205.0 6,876 3,354 
4 Sd 473.60 273.40 200.2 32,194 16,081 
5 Sc 479.11 273.)9 205.9 12,450 6,046 
6 lib 479.58 276.23 203.3 23,529 11,590 
7 Saline 482.49 276.30 206.2 21,645 10,497 
8 480.20 277.31 203.0 19,930 9,817 
9 4c 481.02 278.74 202.3 17,325 8,564 
10 2 483.27 277.55 205.7 8,557 4,159 
II 5d 479.73 278.06 201.7 16,539 8,200 
12. Sc 483.71 279.87 203.8 21,027 10,317 
13· lib 483.7.1 278.93 204.8 15,382 7,510 
14 Saline 493.03. 278.22 214 19,680 9,196 
AVERAGE 
COMPOUND CPM/100 mg % DEVIATION· 
NUMBER TISSUE FROM CONTROL 
Saline 10,719 0.0% 
4c 8,705 -19.94% 
2 3,756 -63.6% 
5d 12,140 +17.4% 




CPM = counts per minute. Glucose-U- 14C activity was 0'.5 millicurie. All compounds were teated in a concentration 
of 250 ma per Ouk. 
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The effects of the compounds on the incorporation of 
lysine -U- 14C into trichloroacetic (TCA) precipitable 
protein of rat testes was investigated by incubating 
about 200 mg of teased testis tubules from mature rats 
1. A compound of the formula: 
in a 25 ml Erlenmeyer flask containing 3 ml of Krebs 5 
Ringer bicarbonate buffer (pH 7.4 ), L-lysine-U-14C 
(0.5 µ,Ci; O. lmM), glucose ( 10 mM) and 0.25 ml of the 
azasteroid to be tested. The flasks were incubated for I 
hour at 33° C under 95% 0 2: 5% CO2 and the TCA 
precipitable protein was isolated and an aliquot used to 10 
measure radioactivity. The results shown in TABLE 6 
indicate that compounds 2, 4c, 5d and I 1 b depress 
protein synthesis by teased testis tubules. The incorpor-
ation of 14C into TCA precipitable material in the pres-







R / .... _.--
EFFECT OF COMPOUNDS ON LYSINE INCORPORATION INTO PROTEIN 
BY RAT TESTIS TUBULES 
TISSUE WEIGHT {mg) 
COMPOUND TARE ACTUAL 
FLASK NUMBER + TARE WEIGHT 
NUMBER TESTED TISSUE ALONE TISSUE CPM/FLASK CPM/100 mg 
17 Saline 461.48 259.11 202.37 3,750 1,852 
19 4c 459.81 263.05 196.76 2,575 1,309 
20 2 464.41 264.51 199.90 2,000 1,000 
21 5d 468.87 265.47 203.4 3,225 1,585 
22 5c 472.62 266.90 205.72 3,325 1,616 
23 I lb 461.71 266.93 194.78 2,325 1,194 
25 Saline 473.12 271.47 201.65 3,550 1,761 
27 4c 473.18 274.19 199.00 2,925 1,470 
28 2 467.78 277.03 190.73 1,200 629 
29 5d 459.19 257.07 202.12 3,125 1,546 
30 5c 465.61 264.30 201.31 4,575 2,273 
31 llb 468.25 268.91 199.34 2,225 1,116 
AVERAGE OF TWO FLASK 





I lb 1,155 
Saline 1,806 
Legend: 
CPM = counts per minute. All compounds were tested in a concentration of 250 mg per flask. 
TABLE 7 
wherein R represents the caroon and hydrogen atoms 
45 necessary to complete one of the following structures: 
Amounts of compounds used for antifertility testing. 
Compound 4c: 4.73 mg. 
50 
R.'OJOOo Compound 2: 8.61 mg. 
Compound 5d: 19.18 mg. 
Compound Sc: 21.36 mg. 
Compound I lb: 4.61 mg. 
It will appear from an examination of the evaluation 
of the compounds that sharp biological effects are 
achieved at exceeding low concentrations. The com- [ l 
pounds are essentially analogs of estrone and equilenin 55 m· · 
and all are characterized by solubility in water. The low · 
concentrations greatly enhance the potential use of . 
these test compounds in human experimentation. At R'O . 
these levels the · compounds are very active and no 
adverse effects have been observed in our experimenta- 60 
tion. 
The methods of preparation set forth herein are by 
way of example and variations and alternative methods R
010
r ~ 
may be obvious to those skilled in the art, all within 
keeping with the spirit and scope of this disclosure. The 65 
new compounds disclosed herein include the optical 
isomers thereof. 
What is claimed: 
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in which R' is a member selected from the group con-
sisting of H, CH3 , bridgehead carbon atom 3a is unsub-
stituted or substituted by H or CH3 in which case the 
only double bond in the pyrazole ring is represented by 
5 
the dashed line and two valences of carbon 3 are satis-
fied by two hydrogen atoms and H is a labile hydrogen 
atom attached to one of two nitrogen atoms, said oxy-
gen being attached to carbon 3 only when said labile 
hydrogen atom is attached to nitrogen number 2 of the 
10 
pyrazole ring. 
2. A compound of the formula: 
24 
wherein the substituent R is the same as in claim I •. 




wherein the substituent R is the same as in claim I and 
RI is a member selected from the group consisting of H 
15 and CH:1-
4. I 0, I I-Dihydro-7-methoxy-3H-naphthindazole. 
5. I 0, I I-Dihydro-3H-naphthindazol-7-ol. 
6. 4,5-Dihydro- I H-benz-7-ol. 
* * * * * 20 
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